Thee was an excursion where Moderna product was stored in the fridge and administered past it's Beyond Use Date; No adverse event; poor quality vaccine administered; Moderna product was stored in the fridge and administered past it's Beyond Use Date.T; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Thee was an excursion where Moderna product was stored in the fridge and administered past it's Beyond Use Date), POOR QUALITY PRODUCT ADMINISTERED (poor quality vaccine administered), EXPIRED PRODUCT ADMINISTERED (Moderna product was stored in the fridge and administered past it's Beyond Use Date.T) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7170B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 19-Feb-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 19-Feb-2023, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (poor quality vaccine administered) and EXPIRED PRODUCT ADMINISTERED (Moderna product was stored in the fridge and administered past it's Beyond Use Date.T). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Thee was an excursion where Moderna product was stored in the fridge and administered past it's Beyond Use Date) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Thee was an excursion where Moderna product was stored in the fridge and administered past it's Beyond Use Date), POOR QUALITY PRODUCT ADMINISTERED (poor quality vaccine administered), EXPIRED PRODUCT ADMINISTERED (Moderna product was stored in the fridge and administered past it's Beyond Use Date.T) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Thee was an excursion where Moderna product was stored in the fridge and administered past it's Beyond Use Date), POOR QUALITY PRODUCT ADMINISTERED (poor quality vaccine administered) and EXPIRED PRODUCT ADMINISTERED (Moderna product was stored in the fridge and administered past it's Beyond Use Date.T).    No concomitant medications was reported. It was unknown whether patient receive any other vaccines in the 4 weeks prior to COVID-19 It was reported that the lot was placed in freezer upon delivery to store. Lot was placed in Store fridge on 17-jan-2023 and a BUD of 16-feb-2023 was applied. Pharmacy team attest to in range temperatures prior to this transfer. Lot was transferred to Store on 1-feb-2023 and administered until 19-2-2023.  Temperature data showed the vaccine was above 46F for a total of approximately 10 hours and 15 min (above 46.4F for 2 hours and 45 minutes). The max temperature reached was 46.958F.  Vial was punctured on 19-feb-2023 at 3:00pm and administered until 4:40pm. No treatment drug details was reported.